MX341450B - Composicion farmaceutica antihipertensiva. - Google Patents

Composicion farmaceutica antihipertensiva.

Info

Publication number
MX341450B
MX341450B MX2013011879A MX2013011879A MX341450B MX 341450 B MX341450 B MX 341450B MX 2013011879 A MX2013011879 A MX 2013011879A MX 2013011879 A MX2013011879 A MX 2013011879A MX 341450 B MX341450 B MX 341450B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
antihypertensive pharmaceutical
solvate
hydrate
pharmaceutically acceptable
Prior art date
Application number
MX2013011879A
Other languages
English (en)
Other versions
MX2013011879A (es
Inventor
Ho Kim Seung
Han Kim Ji
Sang Yu Kyung
Jin Jang In
Goo Shin Sang
Hyun Yoon Seo
Youn Cho Joo
Eun Kim Tae
Jeong Yi So
Heui Paik Soo
Ha Chi Yong
Han Lee Joo
Wan Nam Kyung
Hak Kim Je
Original Assignee
Boryung Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47006840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX341450(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boryung Pharm filed Critical Boryung Pharm
Publication of MX2013011879A publication Critical patent/MX2013011879A/es
Publication of MX341450B publication Critical patent/MX341450B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona una composición farmacéutica antihipertensiva que contiene Fimasartan, una sal farmacéuticamente aceptable del mismo, un solvato del mismo o un hidrato del mismo como un bloqueador del receptor de angiotensina II y Amiodipina, un isómero de la misma, una sal farmacéuticamente aceptable de la misma, un solvato de la misma o un hidrato de la misma como un bloqueador del canal de calcio.
MX2013011879A 2011-04-12 2011-08-08 Composicion farmaceutica antihipertensiva. MX341450B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110033856 2011-04-12
PCT/KR2011/005754 WO2012141385A1 (en) 2011-04-12 2011-08-08 Antihypertensive pharmaceutical composition

Publications (2)

Publication Number Publication Date
MX2013011879A MX2013011879A (es) 2014-03-31
MX341450B true MX341450B (es) 2016-08-19

Family

ID=47006840

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011879A MX341450B (es) 2011-04-12 2011-08-08 Composicion farmaceutica antihipertensiva.

Country Status (20)

Country Link
US (1) US8765776B2 (es)
JP (1) JP5782178B2 (es)
AU (1) AU2011365756B2 (es)
BR (1) BR112013025222B8 (es)
CA (1) CA2832758C (es)
CL (1) CL2013002905A1 (es)
CO (1) CO6821940A2 (es)
CR (1) CR20130526A (es)
EA (1) EA024096B1 (es)
EC (1) ECSP13012962A (es)
GT (1) GT201300241A (es)
MA (1) MA35107B1 (es)
MX (1) MX341450B (es)
MY (1) MY160432A (es)
NI (1) NI201300106A (es)
PE (1) PE20141049A1 (es)
SG (1) SG194162A1 (es)
UA (1) UA110244C2 (es)
WO (1) WO2012141385A1 (es)
ZA (1) ZA201307593B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX341450B (es) 2011-04-12 2016-08-19 Boryung Pharm Composicion farmaceutica antihipertensiva.
KR101490329B1 (ko) * 2012-10-12 2015-02-04 보령제약 주식회사 피마살탄 포타슘염의 일수화물 결정, 그 제조방법, 및 그를 포함하는 약제학적 조성물
KR20140096514A (ko) * 2013-01-28 2014-08-06 보령제약 주식회사 암 예방 또는 치료용 조성물
WO2014142607A1 (ko) * 2013-03-14 2014-09-18 보령제약 주식회사 약제학적 복합제제
KR20150041223A (ko) * 2013-10-04 2015-04-16 보령제약 주식회사 피마살탄을 포함하는 허혈성 뇌질환 예방 또는 치료용 약학적 조성물
CN105395552A (zh) * 2014-09-05 2016-03-16 南京华威医药科技开发有限公司 一种含非马沙坦及其盐的固体制剂
KR101545268B1 (ko) * 2015-02-05 2015-08-20 보령제약 주식회사 정제 및 이의 제조방법
WO2017091041A1 (ko) * 2015-11-26 2017-06-01 보령제약 주식회사 피마살탄의 신규 염
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same
CN112704667A (zh) * 2021-02-24 2021-04-27 施慧达药业集团(吉林)有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
EP0733366B1 (en) 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
KR100300566B1 (ko) 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도
KR19990081093A (ko) 1998-04-25 1999-11-15 조생현 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및 이의제조방법
TR200100062T2 (tr) 1998-07-10 2001-06-21 Novartis Ag Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
KR100617953B1 (ko) 2000-03-23 2006-08-30 보령제약 주식회사 피리미디논 화합물 및 이의 염의 제조방법
EP1436283B1 (en) 2001-09-21 2008-01-23 Boryung Pharmaceutical Co., Ltd. Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
KR100521980B1 (ko) 2002-10-10 2005-10-17 보령제약 주식회사 피리미디논 화합물 및 이의 염의 삼수화물의 제조 방법
TWI405580B (zh) * 2005-06-27 2013-08-21 Sankyo Co 含有血管收縮素ｉｉ接受器拮抗劑及鈣通道阻斷劑之醫藥調配物
KR100888131B1 (ko) * 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제
KR20100048137A (ko) 2008-10-30 2010-05-11 현대약품 주식회사 혈압 강하용 약학 조성물
KR101058284B1 (ko) 2010-01-22 2011-08-22 보령제약 주식회사 2-(2-ｎ-부틸-4-히드록시-6-메틸-피리미딘-5-일)-Ｎ,Ｎ-디메틸아세트아미드의 신규한 제조방법
MX341450B (es) 2011-04-12 2016-08-19 Boryung Pharm Composicion farmaceutica antihipertensiva.

Also Published As

Publication number Publication date
MX2013011879A (es) 2014-03-31
CO6821940A2 (es) 2013-12-31
GT201300241A (es) 2015-08-13
US20120264772A1 (en) 2012-10-18
UA110244C2 (en) 2015-12-10
EA024096B1 (ru) 2016-08-31
JP5782178B2 (ja) 2015-09-24
PE20141049A1 (es) 2014-09-05
ZA201307593B (en) 2015-04-29
AU2011365756B2 (en) 2015-07-30
AU2011365756A1 (en) 2013-10-31
BR112013025222A2 (pt) 2016-12-27
WO2012141385A1 (en) 2012-10-18
EA201370219A1 (ru) 2014-02-28
NI201300106A (es) 2014-05-05
MA35107B1 (fr) 2014-05-02
ECSP13012962A (es) 2013-11-29
BR112013025222B1 (pt) 2020-03-17
CA2832758C (en) 2015-12-15
BR112013025222B8 (pt) 2020-05-05
CA2832758A1 (en) 2012-10-18
JP2014510785A (ja) 2014-05-01
CR20130526A (es) 2014-03-11
MY160432A (en) 2017-03-15
SG194162A1 (en) 2013-11-29
US8765776B2 (en) 2014-07-01
CL2013002905A1 (es) 2014-04-11

Similar Documents

Publication Publication Date Title
MY160432A (en) Antihypertensive pharmaceutical composition
CR20200184A (es) Compuestos útiles para inhibir a cdk7
PH12013500870A1 (en) Heterocyclic compounds and uses thereof
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
MY184303A (en) Notch pathway signaling inhibitor compound
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
WO2012122383A3 (en) Pi3 kinase inhibitors and uses thereof
HK1200315A1 (en) R(+)-n-formyl-propargyl-aminoindan
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
CA2863409A1 (en) N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
UA103996C2 (en) Ivabradine hydrobromide
EA201390603A1 (ru) Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
PH12013501055A1 (en) Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
MX2013008269A (es) Composicion farmaceutica que comprende derivados de piridona.
PH12013500210A1 (en) Highly crystalline valsartan
PH12013501054A1 (en) Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
MX337106B (es) Antagonistas no competitivos de receptores nicotinicos.
WO2012139074A3 (en) Migrastatins and uses thereof
PL401632A1 (pl) Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
WO2013114397A3 (en) Pharmaceutically acceptable salt of brinzolamide and composition thereof
WO2013095042A3 (ko) 이매티닙메실산염 함유 과립, 이를 포함하는 경구용 속방성 정제 조성물 및 그것의 제조방법
JO2775B1 (en) 3-indazolil 4-pyridyl isothiazole
MX2012014969A (es) Composiciones farmaceuticas estables de amlodipina con telmisartan.
TN2013000515A1 (en) Notch pathway signaling inhibitor compound

Legal Events

Date Code Title Description
FG Grant or registration